| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transforming Growth Factor beta1 | 14 | 2022 | 60 | 6.420 |
Why?
|
| Blood Platelets | 13 | 2022 | 203 | 3.610 |
Why?
|
| Thromboplastin | 12 | 2021 | 28 | 1.820 |
Why?
|
| Fibrosis | 6 | 2020 | 115 | 1.580 |
Why?
|
| Aortic Valve Stenosis | 3 | 2020 | 84 | 1.380 |
Why?
|
| Ritonavir | 2 | 2020 | 11 | 1.300 |
Why?
|
| HIV Protease Inhibitors | 2 | 2020 | 14 | 1.300 |
Why?
|
| Liver Cirrhosis | 2 | 2018 | 67 | 1.130 |
Why?
|
| Heart Diseases | 2 | 2017 | 68 | 1.130 |
Why?
|
| HIV Infections | 2 | 2020 | 146 | 1.070 |
Why?
|
| Myocardium | 3 | 2017 | 171 | 1.030 |
Why?
|
| Megakaryocytes | 3 | 2022 | 29 | 1.010 |
Why?
|
| Thrombosis | 4 | 2022 | 147 | 1.000 |
Why?
|
| Mice | 23 | 2023 | 4406 | 0.890 |
Why?
|
| Bone Marrow | 2 | 2022 | 76 | 0.830 |
Why?
|
| Signal Transduction | 15 | 2019 | 1344 | 0.820 |
Why?
|
| Liver | 3 | 2022 | 415 | 0.820 |
Why?
|
| Thrombopoietin | 1 | 2022 | 17 | 0.810 |
Why?
|
| Tenofovir | 1 | 2020 | 7 | 0.710 |
Why?
|
| Animals | 26 | 2023 | 9962 | 0.700 |
Why?
|
| Betacoronavirus | 1 | 2020 | 37 | 0.690 |
Why?
|
| Kidney Diseases | 1 | 2020 | 59 | 0.680 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2020 | 63 | 0.680 |
Why?
|
| Blood Coagulation | 6 | 2008 | 116 | 0.670 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 47 | 0.670 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 51 | 0.670 |
Why?
|
| Vascular Remodeling | 1 | 2019 | 14 | 0.660 |
Why?
|
| Stress, Physiological | 2 | 2019 | 90 | 0.650 |
Why?
|
| Models, Cardiovascular | 1 | 2019 | 46 | 0.640 |
Why?
|
| Pandemics | 1 | 2020 | 166 | 0.640 |
Why?
|
| Collagen | 5 | 2019 | 147 | 0.610 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 159 | 0.610 |
Why?
|
| Carbon Monoxide | 1 | 2017 | 47 | 0.580 |
Why?
|
| Receptor, PAR-2 | 5 | 2007 | 6 | 0.580 |
Why?
|
| Heart-Assist Devices | 1 | 2017 | 26 | 0.580 |
Why?
|
| Endothelial Cells | 6 | 2023 | 324 | 0.570 |
Why?
|
| Radiotherapy | 1 | 2017 | 39 | 0.570 |
Why?
|
| Anti-Retroviral Agents | 1 | 2016 | 15 | 0.530 |
Why?
|
| Latent TGF-beta Binding Proteins | 2 | 2013 | 3 | 0.510 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 278 | 0.510 |
Why?
|
| Protein Disulfide-Isomerases | 2 | 2013 | 6 | 0.500 |
Why?
|
| Humans | 28 | 2023 | 26846 | 0.490 |
Why?
|
| Thrombospondin 1 | 2 | 2017 | 7 | 0.490 |
Why?
|
| Heart Failure | 1 | 2017 | 232 | 0.480 |
Why?
|
| Chemokines | 3 | 2004 | 73 | 0.480 |
Why?
|
| Disulfides | 3 | 2013 | 33 | 0.450 |
Why?
|
| Mice, Inbred C57BL | 9 | 2020 | 1475 | 0.440 |
Why?
|
| Coronary Thrombosis | 1 | 2013 | 36 | 0.440 |
Why?
|
| Wasp Venoms | 1 | 2013 | 2 | 0.430 |
Why?
|
| Coronary Vessels | 1 | 2013 | 151 | 0.410 |
Why?
|
| Receptor Cross-Talk | 2 | 2010 | 11 | 0.410 |
Why?
|
| Disease Models, Animal | 7 | 2022 | 1394 | 0.400 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 346 | 0.400 |
Why?
|
| Receptors, Cell Surface | 2 | 2021 | 109 | 0.380 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 342 | 0.360 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2010 | 75 | 0.360 |
Why?
|
| Peptides | 1 | 2013 | 280 | 0.360 |
Why?
|
| Protein Precursors | 1 | 2010 | 11 | 0.350 |
Why?
|
| Heart | 1 | 2011 | 219 | 0.350 |
Why?
|
| Factor VIIa | 3 | 2007 | 29 | 0.350 |
Why?
|
| Receptors, CXCR4 | 1 | 2010 | 27 | 0.350 |
Why?
|
| Cell Adhesion Molecules | 2 | 2021 | 64 | 0.340 |
Why?
|
| Thymus Gland | 1 | 2010 | 53 | 0.340 |
Why?
|
| Hypertension | 2 | 2014 | 304 | 0.340 |
Why?
|
| Mice, Knockout | 7 | 2022 | 782 | 0.340 |
Why?
|
| Receptor, PAR-1 | 3 | 2008 | 7 | 0.340 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 131 | 0.330 |
Why?
|
| Cell Line | 6 | 2013 | 672 | 0.330 |
Why?
|
| von Willebrand Factor | 2 | 2022 | 36 | 0.310 |
Why?
|
| Platelet Activation | 2 | 2018 | 54 | 0.290 |
Why?
|
| Endotoxemia | 1 | 2007 | 8 | 0.290 |
Why?
|
| Platelet Activating Factor | 2 | 2004 | 7 | 0.260 |
Why?
|
| Cell Communication | 1 | 2006 | 66 | 0.260 |
Why?
|
| Macrophages | 3 | 2007 | 274 | 0.260 |
Why?
|
| Chemokine CCL2 | 3 | 2004 | 43 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2004 | 83 | 0.250 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2004 | 77 | 0.250 |
Why?
|
| Inflammation | 4 | 2022 | 601 | 0.240 |
Why?
|
| Complement C3a | 1 | 2004 | 6 | 0.240 |
Why?
|
| Mast Cells | 1 | 2004 | 9 | 0.240 |
Why?
|
| Receptor, trkA | 1 | 2004 | 9 | 0.230 |
Why?
|
| Nerve Growth Factor | 1 | 2004 | 14 | 0.230 |
Why?
|
| Lipoproteins | 1 | 2004 | 95 | 0.230 |
Why?
|
| Transcription Factors | 3 | 2023 | 511 | 0.230 |
Why?
|
| Protein Binding | 4 | 2013 | 631 | 0.230 |
Why?
|
| Mitral Valve Prolapse | 1 | 2023 | 21 | 0.220 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 93 | 0.220 |
Why?
|
| Heart Valve Diseases | 1 | 2023 | 26 | 0.220 |
Why?
|
| Nuclear Proteins | 2 | 2004 | 245 | 0.210 |
Why?
|
| Sirtuin 3 | 1 | 2022 | 18 | 0.210 |
Why?
|
| Leukotriene C4 | 1 | 2002 | 2 | 0.200 |
Why?
|
| Time Factors | 4 | 2020 | 1563 | 0.200 |
Why?
|
| In Vitro Techniques | 3 | 2013 | 239 | 0.200 |
Why?
|
| Anemia, Sickle Cell | 1 | 2022 | 38 | 0.200 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2022 | 24 | 0.200 |
Why?
|
| Interferon Type I | 1 | 2022 | 55 | 0.200 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 73 | 0.190 |
Why?
|
| Vascular Diseases | 1 | 2022 | 67 | 0.190 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 67 | 0.190 |
Why?
|
| Female | 6 | 2022 | 14463 | 0.190 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 482 | 0.190 |
Why?
|
| Lymphatic Vessels | 1 | 2021 | 17 | 0.190 |
Why?
|
| Capillaries | 1 | 2021 | 32 | 0.190 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 36 | 0.190 |
Why?
|
| Stress, Mechanical | 2 | 2014 | 102 | 0.190 |
Why?
|
| Phosphorylation | 6 | 2004 | 560 | 0.190 |
Why?
|
| Calcium | 5 | 2007 | 231 | 0.180 |
Why?
|
| Mice, Mutant Strains | 4 | 2008 | 58 | 0.180 |
Why?
|
| Blood Proteins | 2 | 2013 | 64 | 0.180 |
Why?
|
| Up-Regulation | 1 | 2021 | 240 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 496 | 0.180 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 26 | 0.180 |
Why?
|
| Heme Oxygenase-1 | 1 | 2020 | 36 | 0.180 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 61 | 0.170 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2020 | 57 | 0.170 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 89 | 0.170 |
Why?
|
| Disease Progression | 2 | 2019 | 450 | 0.170 |
Why?
|
| Health Status | 1 | 2020 | 145 | 0.170 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 486 | 0.170 |
Why?
|
| Smad2 Protein | 1 | 2019 | 16 | 0.170 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2019 | 20 | 0.160 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 43 | 0.160 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2020 | 119 | 0.160 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2019 | 50 | 0.160 |
Why?
|
| Myofibroblasts | 1 | 2019 | 22 | 0.160 |
Why?
|
| Rats | 3 | 2020 | 1545 | 0.160 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 446 | 0.160 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2018 | 5 | 0.160 |
Why?
|
| Lung | 1 | 2021 | 349 | 0.160 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 110 | 0.160 |
Why?
|
| Carbon Tetrachloride | 1 | 2018 | 8 | 0.150 |
Why?
|
| Hepatic Stellate Cells | 1 | 2018 | 14 | 0.150 |
Why?
|
| Antioxidants | 1 | 2020 | 220 | 0.150 |
Why?
|
| Factor Xa | 3 | 2008 | 13 | 0.150 |
Why?
|
| Risk Assessment | 1 | 2020 | 586 | 0.150 |
Why?
|
| Hemodynamics | 1 | 2019 | 220 | 0.150 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 130 | 0.150 |
Why?
|
| Ultrasonography | 1 | 2019 | 228 | 0.150 |
Why?
|
| Computer Simulation | 1 | 2019 | 221 | 0.150 |
Why?
|
| Cardiac Output | 1 | 2017 | 36 | 0.150 |
Why?
|
| Membrane Proteins | 3 | 2014 | 466 | 0.150 |
Why?
|
| Venous Thrombosis | 1 | 2018 | 98 | 0.150 |
Why?
|
| Echocardiography | 1 | 2017 | 107 | 0.140 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 143 | 0.140 |
Why?
|
| Neutrophils | 1 | 2018 | 177 | 0.140 |
Why?
|
| Enzyme Inhibitors | 3 | 2007 | 247 | 0.140 |
Why?
|
| Stroke Volume | 1 | 2017 | 111 | 0.140 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 111 | 0.130 |
Why?
|
| Cysteine | 2 | 2006 | 67 | 0.130 |
Why?
|
| Monocytes | 1 | 2017 | 132 | 0.130 |
Why?
|
| Aged | 2 | 2017 | 5166 | 0.130 |
Why?
|
| Male | 4 | 2017 | 12875 | 0.130 |
Why?
|
| Risk Factors | 1 | 2020 | 2010 | 0.120 |
Why?
|
| Secretory Vesicles | 1 | 2014 | 11 | 0.120 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2014 | 37 | 0.120 |
Why?
|
| Middle Aged | 2 | 2017 | 6820 | 0.120 |
Why?
|
| Hemorheology | 1 | 2014 | 7 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 5 | 2008 | 283 | 0.120 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 58 | 0.120 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 80 | 0.120 |
Why?
|
| Regeneration | 1 | 2014 | 76 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2014 | 155 | 0.110 |
Why?
|
| Crosses, Genetic | 2 | 2011 | 36 | 0.110 |
Why?
|
| Homeostasis | 1 | 2014 | 114 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 2 | 2005 | 144 | 0.110 |
Why?
|
| NF-kappa B | 2 | 2004 | 187 | 0.110 |
Why?
|
| Clusterin | 1 | 2013 | 5 | 0.110 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 2 | 2022 | 4 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 65 | 0.100 |
Why?
|
| Complement Membrane Attack Complex | 2 | 2022 | 13 | 0.100 |
Why?
|
| Alprostadil | 1 | 2011 | 4 | 0.100 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2022 | 20 | 0.100 |
Why?
|
| Skin Abnormalities | 1 | 2011 | 5 | 0.100 |
Why?
|
| Platelet Aggregation | 1 | 2011 | 43 | 0.100 |
Why?
|
| Integrases | 1 | 2011 | 39 | 0.100 |
Why?
|
| Blood Vessels | 1 | 2011 | 58 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 253 | 0.090 |
Why?
|
| Thrombocytopenia | 1 | 2011 | 113 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2010 | 40 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 31 | 0.090 |
Why?
|
| Cytoplasm | 2 | 2007 | 57 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2011 | 259 | 0.080 |
Why?
|
| Carotid Arteries | 1 | 2009 | 52 | 0.080 |
Why?
|
| Enzyme Activation | 3 | 2006 | 262 | 0.080 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2008 | 4 | 0.080 |
Why?
|
| Biophysics | 1 | 2008 | 14 | 0.080 |
Why?
|
| Oxidation-Reduction | 2 | 2006 | 354 | 0.080 |
Why?
|
| Biophysical Phenomena | 1 | 2008 | 9 | 0.080 |
Why?
|
| Culture Media, Conditioned | 1 | 2008 | 31 | 0.080 |
Why?
|
| Sulfhydryl Compounds | 1 | 2008 | 29 | 0.080 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 186 | 0.080 |
Why?
|
| Leukocytes | 2 | 2014 | 67 | 0.080 |
Why?
|
| Annexin A2 | 1 | 2008 | 3 | 0.080 |
Why?
|
| NFATC Transcription Factors | 2 | 2004 | 13 | 0.070 |
Why?
|
| Adenosylhomocysteinase | 1 | 2007 | 1 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2008 | 152 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2007 | 646 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 2018 | 970 | 0.070 |
Why?
|
| Isomerism | 1 | 2006 | 12 | 0.070 |
Why?
|
| Oxidants | 1 | 2006 | 30 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 100 | 0.070 |
Why?
|
| Lymphocyte Activation | 1 | 2007 | 204 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 152 | 0.070 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 50 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2004 | 110 | 0.060 |
Why?
|
| Adult | 1 | 2017 | 7384 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2006 | 151 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2007 | 162 | 0.060 |
Why?
|
| Protein Transport | 2 | 2004 | 152 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 38 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 49 | 0.060 |
Why?
|
| Transfection | 2 | 2004 | 312 | 0.060 |
Why?
|
| Drug Resistance, Microbial | 1 | 2005 | 34 | 0.060 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 29 | 0.060 |
Why?
|
| Proteoglycans | 1 | 2004 | 37 | 0.060 |
Why?
|
| Cricetulus | 1 | 2004 | 56 | 0.060 |
Why?
|
| Arrestins | 1 | 2004 | 2 | 0.060 |
Why?
|
| Calcineurin | 1 | 2004 | 7 | 0.060 |
Why?
|
| CHO Cells | 1 | 2004 | 96 | 0.060 |
Why?
|
| Cricetinae | 1 | 2004 | 129 | 0.060 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2004 | 1 | 0.060 |
Why?
|
| Chemokine CCL4 | 1 | 2004 | 3 | 0.060 |
Why?
|
| Thrombin | 1 | 2004 | 68 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2005 | 91 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2004 | 100 | 0.060 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2003 | 1 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2004 | 106 | 0.060 |
Why?
|
| Anthrax | 1 | 2005 | 85 | 0.060 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 29 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2023 | 12 | 0.060 |
Why?
|
| Mitral Valve | 1 | 2023 | 58 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 1 | 2004 | 123 | 0.050 |
Why?
|
| Proteostasis | 1 | 2022 | 9 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 439 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 59 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2004 | 245 | 0.050 |
Why?
|
| Hemolysis | 1 | 2022 | 46 | 0.050 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2002 | 11 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 25 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 441 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2022 | 115 | 0.050 |
Why?
|
| ADAMTS13 Protein | 1 | 2022 | 126 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2006 | 624 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 100 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2021 | 12 | 0.050 |
Why?
|
| Microvessels | 1 | 2022 | 85 | 0.050 |
Why?
|
| Biopsy | 1 | 2022 | 199 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2022 | 104 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 161 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2002 | 152 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 586 | 0.040 |
Why?
|
| Mitochondria | 1 | 2022 | 333 | 0.040 |
Why?
|
| Umbilical Veins | 2 | 2008 | 25 | 0.040 |
Why?
|
| Neoplasms | 1 | 2005 | 756 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 627 | 0.030 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2014 | 10 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2014 | 52 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2014 | 31 | 0.030 |
Why?
|
| Platelet Transfusion | 1 | 2014 | 29 | 0.030 |
Why?
|
| Diet, Atherogenic | 1 | 2014 | 3 | 0.030 |
Why?
|
| Apolipoprotein B-100 | 1 | 2014 | 4 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2014 | 42 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 2014 | 17 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2014 | 18 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 57 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2014 | 28 | 0.030 |
Why?
|
| Calcinosis | 1 | 2014 | 23 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 100 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 77 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2014 | 90 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 131 | 0.030 |
Why?
|
| Endothelium, Vascular | 2 | 2007 | 305 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2014 | 771 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 67 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2007 | 42 | 0.020 |
Why?
|
| Integrin beta1 | 1 | 2007 | 15 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2007 | 59 | 0.020 |
Why?
|
| Lysine | 1 | 2008 | 71 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2007 | 32 | 0.020 |
Why?
|
| Cell Division | 1 | 2007 | 153 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2007 | 14 | 0.020 |
Why?
|
| Methylation | 1 | 2007 | 21 | 0.020 |
Why?
|
| Adenine | 1 | 2007 | 15 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2007 | 29 | 0.020 |
Why?
|
| Butyrates | 1 | 2007 | 13 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2006 | 22 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2007 | 45 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2007 | 197 | 0.020 |
Why?
|
| Blood Coagulation Factors | 1 | 2006 | 31 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 316 | 0.020 |
Why?
|
| Foam Cells | 1 | 2005 | 8 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2006 | 235 | 0.020 |
Why?
|
| beta-Arrestins | 1 | 2004 | 1 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2004 | 20 | 0.010 |
Why?
|
| Luciferases | 1 | 2004 | 49 | 0.010 |
Why?
|
| Leukotriene B4 | 1 | 2003 | 2 | 0.010 |
Why?
|
| Receptors, Leukotriene | 1 | 2003 | 2 | 0.010 |
Why?
|
| Eye Diseases | 1 | 2004 | 31 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2003 | 44 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2003 | 28 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2005 | 211 | 0.010 |
Why?
|
| Aorta | 1 | 2004 | 123 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 190 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 674 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 1036 | 0.010 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2002 | 1 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 2002 | 5 | 0.010 |
Why?
|
| beta-Adrenergic Receptor Kinases | 1 | 2002 | 7 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 15 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 33 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 820 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 1263 | 0.010 |
Why?
|